Work

A phase I trial of riluzole and sorafenib in patients with advanced solid tumors and melanoma.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.tps3112

Authors: Janice M. Mehnert, Neha Semlani, Yvonne Wen, Antoinette R. Tan, Rebecca Anne Moss, Shari Adams, Mark N. Stein, Mikel Ross, Michael P. Kane, Darlene Gibbon, John Joseph Wright, Joseph Aisner, Suzie Chen, James S Goydos

Institutions: Rutgers Cancer Institute, National Cancer Institute, Rutgers, The State University of New Jersey

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2602339291

Cites:

Cited by: 3

Related to: 10